Page last updated: 2024-10-15

3-hydroxyanthranilic acid and Chagas Disease

3-hydroxyanthranilic acid has been researched along with Chagas Disease in 1 studies

3-Hydroxyanthranilic Acid: An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.
3-hydroxyanthranilic acid : An aminobenzoic acid that is benzoic acid substituted at C-2 by an amine group and at C-3 by a hydroxy group. It is an intermediate in the metabolism of the amino acid tryptophan.
3-hydroxyanthranilate : A hydroxybenzoate that is the conjugate base of 3-hydroxyanthranilic acid.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knubel, CP1
Martínez, FF1
Fretes, RE1
Díaz Lujan, C1
Theumer, MG1
Cervi, L1
Motrán, CC1

Other Studies

1 other study available for 3-hydroxyanthranilic acid and Chagas Disease

ArticleYear
Indoleamine 2,3-dioxigenase (IDO) is critical for host resistance against Trypanosoma cruzi.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010, Volume: 24, Issue:8

    Topics: 3-Hydroxyanthranilic Acid; Animals; Chagas Disease; Host-Parasite Interactions; Indoleamine-Pyrrole

2010